Daniel Kaplan, MD, PhD

Daniel Kaplan, MD, PhD
Request Appointment
Dermatology Clinic
Phillips-Wangensteen Building
Fifth Floor, Clinic 5A
516 Delaware St. SE
Minneapolis, MN 55455

Sees Patients at:

Medical Title:



Clinical Interests:


Board Certifications:

Igyarto B., Kaplan DH., 2010 “The evolving function of Langerhans Cells in Adaptive Skin Immunity.” Immunol Cell Biol. 88(4):361-5.

Bobr A., Olvera-Gomez I., Igyarto BZ., Haley KM., Hogquist KA, Kaplan DH. 2010 “Acute ablation of Langerhans cells enhances skin immune responses.” J. Immunol 185:4724-4728.

Kaplan, DH. 2010. Langerhans cells: not your average dendritic cell. Trends Immunol 31:437.

Kaplan, DH. 2010. In vivo function of Langerhans cells and dermal dendritic cells. Trends Immunol 31:446-451

Nestle, F.O., Kaplan, D.H., Barker, J. 2009 “Psoriasis.” New England Journal of Medicine. 361(5):496-509.

Strid, J., Roberts S.J., Filler, R.B., Lewis, J.M., Kwong, B.Y., Schpero W., Kaplan, D.H., Hayday A.C., Girardi, M. 2008 “NKG2D-ligand upregulation promoted rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis.” Nature Immunology. 9:146-154.

Obhrai, J.S., Oberbarnscheidt, M., Zhang N., Mueller D.L., Shlomchik, W.D., Lakkis, F.G., Shlomchik, M.J., Kaplan, D.H. “Langerhans Cells Are Not Required For Efficient Skin Graft Rejection” 2008, J. Invest. Dermatology, 128:1950-1955.

Kaplan, D.H., Kissenpfennig A., Clausen B.E., “Insights into Langerhans Cell function from LC ablation models” 2008, Eur. J. Immunol.,38:9; 2369-76.

Kaplan, D.H., Jenison, M.D., Li, M.O., Flavell, R.A., Shlomchik, M.J. 2007 “Autocrine TGFb is required for Langerhans Cell Development.” J Exp Med. 204:2545-52.

Kaplan D.H., Jenison, M.C., Shlomchik W.D., Shlomchik M.J. 2005 “Langerhans Cell Deficient Mice Develop Enhanced Contact Hypersensitivity”. Immunity 23:611-620.

 Visit Other Fairview Sites 
(c) 2012 Fairview Health Services. All rights reserved.